Nikroxx file pdf
Embed Size (px)
Transcript of Nikroxx file pdf
ANALYSIS ON M.I.S. REPORTS OF 10
PHARMACEUTICAL COMPANIES OF PAONTA SAHIB
KURUKSHETRA UNIVERSITY, KURUKSHETRA
In partial fulfillment of the requirement for the award of degree
MASTER OF BUSINESS ADMINISTRATION
UNDER SUPERVISION OF- SUBMITTED BY-
Ms. Meenu Bhutani Nikhil Jhamb
GURU NANAK INSTITUTE OF MANAGEMENT
MULLANA, AMBALA (HARYANA)
(Approved by AICTE, Affiliated to Kurukshetra University, Kurukshetra)
I, NIKHIL JHAMB hereby declare that this research entitled Analysis of M.I.S.
Report of various pharmaceutical companies (Mediforce Heathcare Pvt. Ltd.,
Sirmour Remedies Pvt. Ltd., Copmed Pharmaceuticals Pvt. Ltd. UNIT-I,II,III,
Pharma Force Labs UNIT-I,II,III, Relax Pharmaceuticals UNIT-I,II.) submitted
by me for the award of M.B.A. (Final) of Kurukshetra University, Kurukshetra, is the
original work conducted by me and the data provided in the study authentic to the best
of my knowledge.
This research is not submitted to any other Institute or University for the award or
degree of M.B.A.
There is always a sense of gratitude which one can express for others for their help
and supervision in achieving the goals. I too express my deep gratitude to each and
every one who has been helpful to me in completing the Research report successfully.
I also want to convey my sincere sense of gratitude to Mr. Virender Mehta (
H.O.D., M.B.A. Deptt.) for their inspiration & helpful attitude. I would like to grab
the opportunity to thank Ms. Meenu Bhutani ( Faculty, M.B.A. Deptt.) for her
helping hand in the completion of the Research report.
I feel self-short of words to thanks my parents and friends who had directly or
indirectly help me in the completion of the Research report. I would also like to thank
Almighty God for blessing showered on me during the completion of Research
As we are experiencing that Pharmaceuticals is the biggest necessity in any country.
Due to lacking in this sector India is far behind the developed countries. In this
research I have included Indias 10 Pharmaceutical Companies they are induldge in
M.I.S. Reports show the real picture of the companies functions, operations,
liabilities and assets. Study of their M.I.S. Reports show growth of the companies,
that they are earning good profit and as well as distributing good amount of dividends.
In my study, I tried to cover all the financial aspects and throw a light on the
profitability of the companies which shows that there is high risk in the industry in
I have done research on the M.I.S. report of 10 different pharmaceutical companies
and did the interpretation on the basis of sales , profit and overheads of the companies
by comparing it with their last years sales, profit and overheads.
TITLE PAGE NO.
1.1 Pharmaceutical Industry - 1-16
1.2 Company Profile - 17-32
System - 33-43
Chapter 3. Research methodology
3.1 Objective of the study - 44
3.2 Research design - 44
3.3 Data Collection - 45
Chapter 4. Data analysis and interpretation - 46-55
Chapter 5. Findings - 56
Chapter 6. Recommendations and Conclusion - 57-58
Bibliography - 59
Pharmaceutical industry, the discovery, development, and manufacture of drugs and
medications (pharmaceuticals) by public and private organizations. The modern era of
the pharmaceutical industryof isolation and purification of compounds, chemical
synthesis, and computer-aided drug designis considered to have begun in the 19th
century, thousands of years after intuition and trial and error led humans to believe
that plants, animals, and minerals contained medicinal properties. The unification of
research in the 20th century in fields such as chemistry and physiology increased the
understanding of basic drug-discovery processes. Identifying new drug targets,
attaining regulatory approval from government agencies, and refining techniques in
drug discovery and development are among the challenges that face the
pharmaceutical industry today. The continual evolution and advancement of the
pharmaceutical industry is fundamental in the control and elimination
of disease around the world.
The Indian pharmaceutical industry currently tops the chart amongst India's science-
based industries with wide ranging capabilities in the complex field of drug
manufacture and technology. A highly organized sector, the Indian pharmaceutical
industry is estimated to be worth $ 4.5 billion, growing at about 8 to 9 percent
annually. It ranks very high amongst all the third world countries, in terms of
technology, quality and the vast range of medicines that are manufactured.
The Indian pharmaceutical sector is highly fragmented with more than 20,000
registered units. It has expanded drastically in the last two decades. The
Pharmaceutical and Chemical industry in India is an extremely fragmented market
with severe price competition and government price control. The Pharmaceutical
industry in India meets around 70% of the country's demand for bulk drugs, drug
intermediates, pharmaceutical formulations, chemicals, tablets, capsules, orals and
injectibles. There are approximately 250 large units and about 8000 Small Scale
Units, which form the core of the pharmaceutical industry in India (including 5
Central Public Sector Units).
The Government has also played a vital role in the development of the India Software
Industry. In 1986, the Indian government announced a new software policy which
was designed to serve as a catalyst for the software industry. This was followed in
1988 with the World Market Policy and the establishment of the Software
Technology Parks of India (STP) scheme. In addition, to attract foreign direct
investment, the Indian Government permitted foreign equity of up to 100 percent and
duty free import on all inputs and products.
The industry has enormous growth potential. Factors listed below determine the rising
demand for pharmaceuticals.
The growing population of over of a billion
Demand for quality healthcare service
Changing lifestyle has led to change in disease patterns, and increased demand
for new medicines to combat lifestyle related diseases.More than 85 per cent
of the formulations produced in the country are sold in the domestic market.
India is largely self-sufficient in case of formulations. Some life saving, new
generation under-patent formulations continue to be imported, especially by
MNCs, which then market them in India. Overall, the size of the domestic
formulations market is around Rs160 billion and it is growing at 10 per cent
Diagnostic Outsourcing/ Clinical Trails
The Indian diagnostic services are projected to grow at a CAGR of more than 20 per
cent during 2010-2012.
Some of the major Indian pharmaceutical firms, including Sun Pharma, Cadilla
Healthcare and Piramal Life Sciences, had applied for conducting clinical trials on at
least 12 new drugs in 2010, indicating a growing interest in new drug discovery